Pomaglumetad Methionil (LY2140023 Monohydrate) and Aripiprazole in Patients with Schizophrenia: A Phase 3, Multicenter, Double-Blind Comparison
Figure 3
Least-squares mean change of the weight from mixed-effects model repeated measures among intent-to-treat (ITT) patients with schizophrenia in pomaglumetad methionil () and aripiprazole () treatment groups for 24 weeks of double-blind treatment. *. values are from type III tests of LS mean differences between treatments at each visit from MMRM. LS mean: least-squares means, MMRM: mixed-effects model with repeated measures, and SE: standard error.
